Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
- John W. Eikelboom
- , Sanjit S. Jolly
- , Emilie P. Belley-Cote
- , Richard P. Whitlock
- , Sumathy Rangarajan
- , Lizhen Xu
- , Laura Heenan
- , Shrikant I. Bangdiwala
- , Wadea M. Tarhuni
- , Mohamed Hassany
- , Anna Kontsevaya
- , William Harper
- , Sanjib Kumar Sharma
- , Patricio Lopez-Jaramillo
- , Antonio L. Dans
- , Lia M. Palileo-Villanueva
- , Alvaro Avezum
- , Prem Pais
- , Denis Xavier
- , Camilo Felix
- Hamilton Health Sciences
- McMaster University
- University of Saskatchewan
- Western University
- The Windsor Cardiac Centre
- National Hepatology and Tropical Research Institute
- Russian Ministry of Health
- B P Koirala Institute of Health Sciences
- Universidad de Santander
- University of the Philippines
- Hospital Alemão Oswaldo Cruz
- St. John's National Academy of Health Sciences
- Universidad Tecnológica Equinoccial
- Duke University
- Hospital Israelita Albert Einstein
- Jinnah Sindh Medical University
- University of Cape Town
- Medical & Scientific Affairs
- University of Toronto
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations